Literature DB >> 31741179

Axillary lymph node dissection in node-positive breast cancer: are ten nodes adequate and when is enough, enough?

Laura H Rosenberger1,2,3, Yi Ren4,5, Samantha M Thomas4,5, Rachel A Greenup6,4, Oluwadamilola M Fayanju6,4, E Shelley Hwang6,4, Jennifer K Plichta6,4.   

Abstract

PURPOSE: National guidelines define adequate axillary lymph node dissections as those yielding ≥ 10 lymph nodes (LNs). We aimed to identify the optimal LN yield among node-positive patients.
METHODS: Using the National Cancer Data Base (2010-2015), we categorized node-positive patients as follows: (1) neoadjuvant chemotherapy (NAC, cN1-3 or ypN1mi-3) or (2) upfront surgery (pN1-3). A restricted cubic splines model was used to estimate LN retrieval thresholds associated with change in overall survival (OS).
RESULTS: 129,685 patients were identified: 21.2% NAC, 78.8% upfront surgery. Low, moderate, and high retrieval thresholds were estimated to be 1-6, 7-21, and > 21 LNs (upfront surgery), and 1-7, 8-22, and > 22 LNs (NAC). In an adjusted model, high versus low LN yield was associated with greater receipt of adjuvant chemotherapy (upfront surgery OR 1.96, p < 0.001) and greater use of adjuvant radiation (upfront surgery OR 1.08, p = 0.02; NAC OR 1.23, p = 0.002). After adjustment, high versus low LN retrieval was associated with improved OS (upfront surgery HR 0.86, p < 0.001; NAC HR 0.77, p < 0.001). Worse OS was associated with retrieving fewer LNs, likely as a result of an under-staged axilla and missed opportunity for adjuvant therapy, while better OS was independently associated with retrieval of up to approximately 20 LNs, after which survival did not improve.
CONCLUSION: In node-positive breast cancer, the number of nodes retrieved is significantly associated with an increased positive nodal count and greater use of adjuvant therapy. Removal of approximately 20 LNs may improve survival by both more accurate nodal staging and increased adjuvant therapy use.

Entities:  

Keywords:  Axillary lymph node dissection; Breast cancer; Guidelines; Node-positive; Overall survival; Staging

Mesh:

Year:  2019        PMID: 31741179      PMCID: PMC7049074          DOI: 10.1007/s10549-019-05500-9

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  23 in total

1.  Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases.

Authors:  C L Carter; C Allen; D E Henson
Journal:  Cancer       Date:  1989-01-01       Impact factor: 6.860

2.  Prognostic significance of total number of nodes removed, negative nodes removed, and ratio of positive nodes to removed nodes in node positive breast carcinoma.

Authors:  B Kuru
Journal:  Eur J Surg Oncol       Date:  2006-08-01       Impact factor: 4.424

3.  Population-based validation of the prognostic model ADJUVANT! for early breast cancer.

Authors:  Ivo A Olivotto; Chris D Bajdik; Peter M Ravdin; Caroline H Speers; Andrew J Coldman; Brian D Norris; Greg J Davis; Stephen K Chia; Karen A Gelmon
Journal:  J Clin Oncol       Date:  2005-04-20       Impact factor: 44.544

Review 4.  Development of axillary surgery in breast cancer.

Authors:  A Luini; G Gatti; B Ballardini; S Zurrida; V Galimberti; P Veronesi; A R Vento; S Monti; G Viale; G Paganelli; U Veronesi
Journal:  Ann Oncol       Date:  2005-02       Impact factor: 32.976

5.  Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.

Authors:  Armando E Giuliano; Kelly K Hunt; Karla V Ballman; Peter D Beitsch; Pat W Whitworth; Peter W Blumencranz; A Marilyn Leitch; Sukamal Saha; Linda M McCall; Monica Morrow
Journal:  JAMA       Date:  2011-02-09       Impact factor: 56.272

6.  Internal Mammary and Medial Supraclavicular Irradiation in Breast Cancer.

Authors:  Philip M Poortmans; Sandra Collette; Carine Kirkove; Erik Van Limbergen; Volker Budach; Henk Struikmans; Laurence Collette; Alain Fourquet; Philippe Maingon; Mariacarla Valli; Karin De Winter; Simone Marnitz; Isabelle Barillot; Luciano Scandolaro; Ernest Vonk; Carla Rodenhuis; Hugo Marsiglia; Nicola Weidner; Geertjan van Tienhoven; Christoph Glanzmann; Abraham Kuten; Rodrigo Arriagada; Harry Bartelink; Walter Van den Bogaert
Journal:  N Engl J Med       Date:  2015-07-23       Impact factor: 91.245

7.  Axillary dissection of level I and II lymph nodes is important in breast cancer classification. The Danish Breast Cancer Cooperative Group (DBCG).

Authors:  C K Axelsson; H T Mouridsen; K Zedeler
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

8.  Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection.

Authors:  Abigail S Caudle; Wei T Yang; Savitri Krishnamurthy; Elizabeth A Mittendorf; Dalliah M Black; Michael Z Gilcrease; Isabelle Bedrosian; Brian P Hobbs; Sarah M DeSnyder; Rosa F Hwang; Beatriz E Adrada; Simona F Shaitelman; Mariana Chavez-MacGregor; Benjamin D Smith; Rosalind P Candelaria; Gildy V Babiera; Basak E Dogan; Lumarie Santiago; Kelly K Hunt; Henry M Kuerer
Journal:  J Clin Oncol       Date:  2016-01-25       Impact factor: 44.544

9.  How many ELNs are optimal for breast cancer patients with more than three PLNs who underwent MRM? A large population-based study.

Authors:  Xiaohui Wang; Changbin Ji; Huiying Chi; Haiyong Wang
Journal:  Onco Targets Ther       Date:  2018-02-26       Impact factor: 4.147

10.  Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials.

Authors:  P McGale; C Taylor; C Correa; D Cutter; F Duane; M Ewertz; R Gray; G Mannu; R Peto; T Whelan; Y Wang; Z Wang; S Darby
Journal:  Lancet       Date:  2014-03-19       Impact factor: 79.321

View more
  4 in total

1.  Evaluating Axillary Lymph Node Yield After Neoadjuvant Chemotherapy.

Authors:  Betty Fan; Kelsey Romatoski; Jaime Pardo; Monica Valero; Stephanie Serres; Rene Flores; Ted James
Journal:  Ann Surg Oncol       Date:  2022-08-26       Impact factor: 4.339

2.  Surgical Management of the Axilla in Elderly Women With Node-Positive Breast Cancer.

Authors:  Caitlin E Marks; Yi Ren; Laura H Rosenberger; Samantha M Thomas; Rachel A Greenup; Oluwadamilola M Fayanju; Susan McDuff; Gretchen Kimmick; E Shelley Hwang; Jennifer K Plichta
Journal:  J Surg Res       Date:  2020-05-29       Impact factor: 2.192

3.  Extent of axillary surgery in inflammatory breast cancer: a survival analysis of 3500 patients.

Authors:  Oluwadamilola M Fayanju; Yi Ren; Rachel A Greenup; Jennifer K Plichta; Laura H Rosenberger; Jeremy Force; Gita Suneja; Gayathri R Devi; Tari A King; Faina Nakhlis; Terry Hyslop; E Shelley Hwang
Journal:  Breast Cancer Res Treat       Date:  2020-01-20       Impact factor: 4.872

4.  Characterization of surface markers on extracellular vesicles isolated from lymphatic exudate from patients with breast cancer.

Authors:  Karin Ekström; Rossella Crescitelli; Hafsteinn Ingi Pétursson; Junko Johansson; Cecilia Lässer; Roger Olofsson Bagge
Journal:  BMC Cancer       Date:  2022-01-10       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.